BioLife Solutions Inc
NASDAQ:BLFS

Watchlist Manager
BioLife Solutions Inc Logo
BioLife Solutions Inc
NASDAQ:BLFS
Watchlist
Price: 27.39 USD 4.9% Market Closed
Market Cap: 1.3B USD
Have any thoughts about
BioLife Solutions Inc?
Write Note

Gross Margin
BioLife Solutions Inc

46.2%
Current
35%
Average
47.1%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
46.2%
=
Gross Profit
54.7m
/
Revenue
118.4m

Gross Margin Across Competitors

Country US
Market Cap 1.3B USD
Gross Margin
46%
Country JP
Market Cap 6.8T JPY
Gross Margin
86%
Country CH
Market Cap 37.6B CHF
Gross Margin
55%
Country DK
Market Cap 179.6B DKK
Gross Margin
68%
Country US
Market Cap 15.8B USD
Gross Margin
70%
Country CN
Market Cap 51.5B CNY
Gross Margin
72%
Country CA
Market Cap 6.3B USD
Gross Margin
61%
Country KR
Market Cap 9.1T KRW
Gross Margin
15%
Country US
Market Cap 6.2B USD
Gross Margin
65%
Country UK
Market Cap 4.5B GBP
Gross Margin
56%
Country US
Market Cap 5.7B USD
Gross Margin
47%
No Stocks Found

BioLife Solutions Inc
Glance View

Market Cap
1.3B USD
Industry
Health Care

BioLife Solutions Inc., hailing from Bothell, Washington, tells a story of innovation within the niche yet critical biopreservation industry. Emerging as a vital player for cell and gene therapy developers, BioLife Solutions specializes in creating hypothermic storage and transport media tailored for fragile biologic material. Their cornerstone products, like CryoStor and HypoThermosol, are formulated to prolong the shelf-life and viability of cells, tissues, and organs during storage and transportation. These solutions are designed for ultra-cold environments, ensuring the cellular integrity required by biopharmaceutical companies and research institutions engaged in the leading-edge development of regenerative medicine. The company's business model is centered around both direct sales and strategic partnerships. By deeply embedding its proprietary preservation media into clinical-grade processes, BioLife Solutions establishes itself as an integral component of its clients' supply chains. In doing so, the company generates revenue not just from initial sales of its products, but from ongoing usage as therapies move through development pipelines into mainstream clinical applications. Additionally, their diversification into automated thawing devices and personalized medicine services bolster recurring revenue streams, positioning them strategically in an expanding market driven by technological advancements in cellular therapies. Thus, BioLife Solutions stands firmly at the confluence of innovation and necessity, drawing strength from its strategic foresight and commitment to preserving the future of medicine.

BLFS Intrinsic Value
7.18 USD
Overvaluation 74%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
46.2%
=
Gross Profit
54.7m
/
Revenue
118.4m
What is the Gross Margin of BioLife Solutions Inc?

Based on BioLife Solutions Inc's most recent financial statements, the company has Gross Margin of 46.2%.